5th DIA Cardiac Safety Workshop in Japan

Boaz Mendzelevski, MD

Consultant Cardiologist

Atsushi Sugiyama, MD, PhD

Professor and Chairman, Department of Pharmacology

The Current Trends and Issues on Integrated Cardiac Safety

Atsushi Sugiyama, MD, PhD

Toho University Faculty of Medicine, Japan

Professor and Chairman, Department of Pharmacology

Impacts of CiPA on Cost-benefit Performance in a Drug Development

Kentaro Ando, PhD

Toho University Faculty of Medicine, Japan

Department of Pharmacology

In vitro Assay: iPS-cell Derived Cardiomyocytes (tentative)

Yasunari Kanda, PhD

National Institute of Health Sciences, Japan

Head of Division of Pharmacology

Potential Applications of Heart Simulation to the Safety Pharmacology Study in the Future

Takashi Ashihara, MD, PhD

Shiga University of Medical Sciences, Japan

Associate Professor, Dept of Cardiovascular Medicine

In Silico Cardiac Safety Assessment of Drug Effects on Multiple Ionic Currents Using the Heart Simulator

Jun-ichi Okada, PhD

The University of Tokyo, Japan

Graduate School of Frontier Sciences

The Thorough QT/QTc Studies - Current Status in Japan

Yuji Kumagai, MD, PhD

Kitasato University Hospital, Japan

Professor, Kitasato Clinical Research Center

The Utility of Phase 1 QT Data to Replace the Thorough QT Study

Hiroyuki Fukase, MD, PhD

Clinical Research Hospital Tokyo, Japan

Director, Clinical Research Center

Genetic and Clinical Characteristics of Infants, Children and Adolescents with Long QT Syndrome in Japan

Masao Yoshinaga, MD, PhD

National Hospital Organization Kagoshima Medical Center, Japan

Chief Director, Dept of Pediatrics

Panel Discussion

All Session Speakers, United States